Concepedia

Juan Antonio Requena-Ibáñez

JA

Statistics

Publications

12

Citations

1.8K

H-Index

11

Active since

2019

Affiliations

Icahn School of Medicine at Mount Sinai(Current)

Centro de Investigación en Red en Enfermedades Cardiovasculares

University Medical Centre Mannheim

Cardiovascular Institute of the South

Hospital General Universitario de Ciudad Real

Juan Antonio Requena-Ibáñez is an author at Icahn School of Medicine at Mount Sinai specializing in medicine, cardiovascular disease, and diabetes.

ORCID

Top concepts

Publications per year

2019–2024

12

Publications

12

Empagliflozin Ameliorates Adverse Left Ventricular Remodeling in Nondiabetic Heart Failure by Enhancing Myocardial Energetics

Carlos G. Santos‐Gallego, Juan Antonio Requena-Ibáñez, Rodolfo San Antonio et al. · Journal of the American College of Cardiology · 2019 · 633 citations

, , +8

Randomized Trial of Empagliflozin in Nondiabetic Patients With Heart Failure and Reduced Ejection Fraction

Carlos G. Santos‐Gallego, Ariana P. Vargas-Delgado, Juan Antonio Requena-Ibáñez et al. · Journal of the American College of Cardiology · 2020 · 492 citations

, , +7

Mechanistic Insights of Empagliflozin in Nondiabetic Patients With HFrEF

Juan Antonio Requena-Ibáñez, Carlos G. Santos‐Gallego, Anderly Rodriguez-Cordero et al. · JACC Heart Failure · 2021 · 244 citations

, , +10

Empagliflozin Ameliorates Diastolic Dysfunction and Left Ventricular Fibrosis/Stiffness in Nondiabetic Heart Failure

Carlos G. Santos‐Gallego, Juan Antonio Requena-Ibáñez, Rodolfo San Antonio et al. · JACC. Cardiovascular imaging · 2020 · 183 citations

, , +9

Cardioprotective Effect of Empagliflozin and Circulating Ketone Bodies During Acute Myocardial Infarction

Carlos G. Santos‐Gallego, Juan Antonio Requena-Ibáñez, Belén Picatoste et al. · Circulation Cardiovascular Imaging · 2023 · 74 citations

1–5 of 12